We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Williams-Sonoma
WSM
$27.8B
| $1.5M | ﹤0.01% |
39,208
+13,960
| +55% | +$568K |
|
1452
EnerSys
ENS
$6.69B
| $1.5M | ﹤0.01% |
27,908
-993
| -3% | -$57.3K |
|
1453
ONE Gas
OGS
$5.06B
| $1.49M | ﹤0.01% |
32,874
-1,505
| -4% | -$65.9K |
|
1454
Bright Horizons
BFAM
$4.24B
| $1.49M | ﹤0.01% |
23,172
-1,012
| -4% | -$62.4K |
|
1455
Cathay General Bancorp
CATY
$4.25B
| $1.49M | ﹤0.01% |
49,670
-1,934
| -4% | -$60.4K |
|
|
CLC
1456
DELISTED
Clarcor
CLC
| $1.49M | ﹤0.01% |
31,179
-1,317
| -4% | -$74.6K |
|
1457
Broadridge
BR
$18.3B
| $1.49M | ﹤0.01% |
26,836
+8,942
| +50% | +$481K |
|
1458
Haverty Furniture Companies
HVT
$421M
| $1.47M | ﹤0.01% |
62,631
-49
| -0.1% | -$1.13K |
|
|
CLCT
1459
DELISTED
Collectors Universe
CLCT
| $1.47M | ﹤0.01% |
97,339
-124
| -0.1% | -$2.3K |
|
|
MDSO
1460
DELISTED
Medidata Solutions, Inc.
MDSO
| $1.47M | ﹤0.01% |
34,840
-3,414
| -9% | -$173K |
|
1461
Home BancShares
HOMB
$6.31B
| $1.46M | ﹤0.01% |
72,076
-2,434
| -3% | -$47.3K |
|
|
BMR
1462
DELISTED
BIOMED REALTY TRUST INC
BMR
| $1.46M | ﹤0.01% |
73,039
+43,199
| +145% | +$864K |
|
1463
First Industrial Realty Trust
FR
$8.77B
| $1.46M | ﹤0.01% |
69,491
-2,235
| -3% | -$44.9K |
|
|
FMBI
1464
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $1.46M | ﹤0.01% |
83,033
-2,462
| -3% | -$44.8K |
|
|
HPY
1465
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
| $1.45M | ﹤0.01% |
23,062
-14,046
| -38% | -$836K |
|
|
RRMS
1466
DELISTED
ROSE ROCK MIDSTREAM L P COM UNIT REPSTG LTD (DE)
RRMS
| $1.45M | ﹤0.01% |
59,594
-210
| -0.4% | -$7.31K |
|
|
CEB
1467
DELISTED
CEB Inc.
CEB
| $1.44M | ﹤0.01% |
21,094
-964
| -4% | -$74.5K |
|
|
CVG
1468
DELISTED
Convergys
CVG
| $1.44M | ﹤0.01% |
62,259
-2,268
| -4% | -$53.9K |
|
1469
Raymond James Financial
RJF
$34B
| $1.44M | ﹤0.01% |
43,412
+14,972
| +53% | +$555K |
|
1470
Matsons
MATX
$6.15B
| $1.44M | ﹤0.01% |
37,294
+2,091
| +6% | +$82.6K |
|
1471
Primerica
PRI
$10B
| $1.43M | ﹤0.01% |
31,804
-1,953
| -6% | -$85.5K |
|
|
CADE
1472
DELISTED
Cadence Bank
CADE
| $1.43M | ﹤0.01% |
60,178
-2,066
| -3% | -$50.9K |
|
1473
Chemed
CHE
$6.87B
| $1.43M | ﹤0.01% |
10,680
-513
| -5% | -$71.8K |
|
|
IL
1474
DELISTED
IntraLinks Holdings Inc.
IL
| $1.43M | ﹤0.01% |
171,916
+64,733
| +60% | +$687K |
|
|
OSIR
1475
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $1.42M | ﹤0.01% |
77,030
-18,097
| -19% | -$349K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.